Home โ€บ Stock analysis โ€บ DXR

Daxor (DXR) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

DXR dips 1.5% to $10.05, a 1-month low. Closed at $10.05, -1.47% vs the prior close of $10.20. Day range $10.05โ€“$10.17, opened at $10.17.

Last close$10.05-1.47%
Day range10.05โ€“10.17
Open10.17
Volume4.46K
52-week range8.56โ€“14.76
Avg volume (20d)15.72K

DXR daily analysis โ€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 โ€” DXR dips 1.5% to $10.05, a 1-month low
Oct 15, 2026 โ€” DXR rises 1.1% to $10.20
Oct 14, 2026 โ€” DXR dips 2.5% to $10.09, a 1-month low
Oct 13, 2026 โ€” DXR rises 0.5% to $10.35
Oct 12, 2026 โ€” DXR dips 1.1% to $10.30, 3 down days in a row
Oct 9, 2026 โ€” DXR dips 0.5% to $10.41
Oct 8, 2026 โ€” DXR dips 0.5% to $10.46
Oct 7, 2026 โ€” DXR rises 2.0% to $10.51
Oct 6, 2026 โ€” DXR slides 3.1% to $10.30
Oct 5, 2026 โ€” DXR ends flat (+0.1%) to $10.63
Oct 2, 2026 โ€” DXR slides 3.3% to $10.62, 3 down days in a row

DXR latest news & SEC filings

Every SEC filing by or about DXR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 9, 2026 ยท Form 40-8F-2/A โ€” 40-8F-2/A filing

40-8F-2/A filing

Source: SEC EDGAR filing 0000897069-26-001833

Sep 24, 2026 ยท Form N-CEN/A โ€” N-CEN/A filing

N-CEN/A filing

Source: SEC EDGAR filing 0001493152-26-044184

Sep 4, 2026 ยท Form 40-8F-2/A โ€” 40-8F-2/A filing

40-8F-2/A filing

Source: SEC EDGAR filing 0000897069-26-001752

Sep 1, 2026 ยท Form 4 โ€” Insider trade

Insider trade report (Form 4) โ€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001493152-26-040999

Aug 31, 2026 ยท Form NPORT-P โ€” NPORT-P filing

NPORT-P filing

Source: SEC EDGAR filing 0001493152-26-040882

Aug 31, 2026 ยท Form N-CSR โ€” N-CSR filing

N-CSR filing

Source: SEC EDGAR filing 0001493152-26-040876

Aug 31, 2026 ยท Form N-PX โ€” Annual proxy voting record

Annual proxy voting record

Source: SEC EDGAR filing 0001493152-26-040701

Jun 25, 2026 ยท Form 4 โ€” Insider trade

Insider trade report (Form 4) โ€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001493152-26-030197

Jun 25, 2026 ยท Form 4 โ€” Insider trade

Insider trade report (Form 4) โ€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001493152-26-030192

Jun 25, 2026 ยท Form 4 โ€” Insider trade

Insider trade report (Form 4) โ€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001493152-26-030187

Jun 25, 2026 ยท Form 4 โ€” Insider trade

Insider trade report (Form 4) โ€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001493152-26-030180

Jun 25, 2026 ยท Form 4 โ€” Insider trade

Insider trade report (Form 4) โ€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001493152-26-030175

Jun 24, 2026 ยท Form 8-K โ€” Major event / current report

Current report โ€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-029924

Things to know before you trade DXR

DXR market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202610.1710.1710.0510.054.46K
Oct 15, 202610.3610.3610.0810.2024.40K
Oct 14, 202610.5010.509.9510.0915.50K
Oct 13, 202610.3610.5810.0710.3519.60K
Oct 12, 202610.4910.4910.2110.304.80K
Oct 9, 202610.5110.7110.4110.417.50K
Oct 8, 202610.6710.6710.3610.463.50K
Oct 7, 202610.4110.7810.0210.517.40K
Oct 6, 202610.4310.4310.3010.302.90K
Oct 5, 202610.6011.0710.5010.6330.30K
Oct 2, 202610.7210.7910.5010.628.20K
Oct 1, 202611.1811.3510.5510.9816.10K
Sep 30, 202611.7011.7710.9911.2530.00K
Sep 29, 202610.7911.8610.7911.7034.30K
Sep 28, 202610.8011.5910.4411.3511.70K
Sep 25, 202611.4111.4110.4611.0116.40K
Sep 24, 202610.9611.6110.6311.3926.80K
Sep 23, 202611.1511.1510.6210.8211.40K
Sep 22, 202610.9511.5010.9011.2321.10K
Sep 21, 202611.2011.6111.0011.1818.10K

About Daxor

Daxor (DXR) is listed on the Nasdaq and classified by the SEC under โ€œโ€”โ€. Its business address is in OAK RIDGE, TN. State of incorporation: NY. Fiscal year ends December 31. SEC CIK 27367.

DXR board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Henry D. CremisiDirectorJun 25, 2026
Caleb DesrosiersDirectorJun 25, 2026
Jonathan Adam FeldschuhChief Scientific OfficerJun 25, 2026
Michael Richard FeldschuhChief Executive OfficerJun 25, 2026
Edward FeuerDirectorJun 25, 2026
Joy S. GoudieDirectorJun 25, 2026

Executive officers

NameTitleLatest filing
Jonathan Adam FeldschuhChief Scientific OfficerJun 25, 2026
Michael Richard FeldschuhChief Executive OfficerJun 25, 2026
John JefferiesChief Medical OfficerSep 1, 2026
Robert J MichelChief Financial OfficerJun 25, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Apr 8, 2026Michael Richard FeldschuhBuy1,000$9.07
Apr 8, 2026Michael Richard FeldschuhBuy1,000$9.07
Apr 8, 2026Michael Richard FeldschuhBuy1,000$9.07
Apr 8, 2026Michael Richard FeldschuhBuy1,000$9.07
Mar 31, 2026Robert J MichelBuy1,000$9.90
Mar 31, 2026Robert J MichelBuy1,000$9.90
Mar 31, 2026Robert J MichelBuy1,000$9.90
Mar 31, 2026Robert J MichelBuy1,000$9.90
Mar 20, 2026John JefferiesBuy2,285โ€”
Mar 20, 2026John JefferiesBuy3,656โ€”
Mar 20, 2026John JefferiesBuy2,285โ€”
Mar 20, 2026John JefferiesBuy3,656โ€”
Mar 20, 2026John JefferiesBuy2,285โ€”
Mar 20, 2026John JefferiesBuy3,656โ€”
Mar 20, 2026John JefferiesBuy2,285โ€”

DXR financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2011$1.45M$-7.19Mโ€”$-6.51M
Dec 31, 2010$1.58M$4.97Mโ€”$-5.69M

Latest balance sheet: total assets $85.72M, total liabilities $49.51M, cash $59.62K (as of Dec 31, 2011).

DXR earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on DXR

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.